Raphael Pharmaceutical INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
Raphael Pharmaceutical Inc. has amended its Articles of Incorporation to increase the authorized shares of common stock from 21,020,560 to 50,000,000, approved by a majority of stockholders via written consent.